# Specification Quality Checklist: Tumour-Marker Clinical Rules

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-11-08
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- This is a clinical-engine feature in a repo whose specs name engine concepts (`_engine.tests`, `has_critical`, `MEDICAL_RULES.md`); these are contract/process names the user's request imposes, not framework choices. Judged acceptable, consistent with specs 012/013.
- Zero clarification markers: smoking status (default = explicit three-band, no new profile field) and urgency-above-range (cite source or lower and document) were resolved as documented assumptions/requirements.
- Spec corrects the request's premise: tumour markers are already mapped (P77) and CA 125 «0-35» already works; the failing rows are CEA (two-band) and CA 15-3 («At or below»).
